pharmacie et médicaments – Déremboursement des médicaments contre les symptômes de l'Alzheimer

This written question concerns the reimbursement status of drugs used to treat Alzheimer's symptoms in France. It seeks clarification on the national health insurance's policies regarding these medications. The question affects patients with Alzheimer's disease, their families, and healthcare providers. It may lead to changes in access to or cost of these treatments.